VeriMomsymphytum officinale root extract은 임신 중 안전한가요?
Symphytum officinale (comfrey) root/leaf extracts contain pyrrolizidine alkaloids (PAs) that are hepatotoxic, genotoxic and associated with carcinogenicity and reported fetal/veno‑occlusive effects; regulatory bodies caution against internal use in pregnancy and some authorities advise avoiding topical use in pregnancy because of PA-related risks (EMA monograph; PubMed reviews). Skin‑permeation studies show PAs are poorly absorbed through intact human skin but measurable, so topical exposure is low but not zero. (Sources: EMA herbal monograph; PubMed review of Symphytum species; human skin permeation study).
Pregnancy-safe products containing symphytum officinale root extract
임신 중 symphytum officinale root extract 대체 안전 성분 | VeriMom
Related ingredients
Frequently asked questions
- symphytum officinale root extract은 임신 중 안전한가요?
- Symphytum officinale (comfrey) root/leaf extracts contain pyrrolizidine alkaloids (PAs) that are hepatotoxic, genotoxic and associated with carcinogenicity and reported fetal/veno‑occlusive effects; regulatory bodies caution against internal use in pregnancy and some authorities advise avoiding topical use in pregnancy because of PA-related risks (EMA monograph; PubMed reviews). Skin‑permeation studies show PAs are poorly absorbed through intact human skin but measurable, so topical exposure is low but not zero. (Sources: EMA herbal monograph; PubMed review of Symphytum species; human skin permeation study).
- symphytum officinale root extract은 모유 수유 중 안전한가요?
- Because PAs in comfrey are hepatotoxic and have been implicated in infant toxicity and are discouraged during lactation, breastfeeding is cautioned; dermal/topical exposure can result in measurable but low absorption and there are case reports and regulatory warnings advising avoidance with nursing due to risk to the suckling infant. Mechanism is PA metabolic activation with genotoxic/hepatotoxic effects. (Sources: EMA monograph; regulatory advisories; PubMed reviews).
- symphytum officinale root extract은 아기 피부에 안전한가요?
- Infants (0–3 yr) have higher skin permeability and higher surface‑area‑to‑weight, so exposure score is increased. Given comfrey’s content of pyrrolizidine alkaloids (hepatotoxic/genotoxic), and documented infant/fetal cases and regulatory cautions (including advice to avoid use on nursing mothers and infants), residual PA on skin or transfer via breast/chest application could pose risk; although dermal PA absorption was shown to be low in one ex vivo study, infant susceptibility and cases justify conservative approach. (Sources: PubMed review; skin permeation study; regulatory guidance).
- VeriMom은 symphytum officinale root extract을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 symphytum officinale root extract을 40/100 (중간 위험)로 평가합니다.
- 임신 중 symphytum officinale root extract 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.